- Stocks
- Healthcare
- NYSE: PFE

Price (delayed)

$53.58

Market cap

$300.74B

P/E Ratio

15.67

Dividend/share

$1.56

EPS

$3.42

Enterprise value

$338.65B

Pfizer Inc. is an American multinational pharmaceutical corporation. It is one of the world's largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United

Pfizer's net income has surged by 140% YoY and by 53% QoQ

Pfizer's EPS has soared by 139% YoY and by 53% from the previous quarter

The gross margin has contracted by 20% YoY and by 9% from the previous quarter

What are the main financial stats of PFE

Market
Valuations
Earnings

Shares outstanding

5.61B

Market cap

$300.74B

Enterprise value

$338.65B

Price to earnings (P/E)

15.67

Price to book (P/B)

3.97

Price to sales (P/S)

4.73

EV/EBIT

16.76

EV/EBITDA

13.46

EV/Sales

5.32

Revenue

$63.6B

EBIT

$20.21B

EBITDA

$25.17B

Free cash flow

$29.29B

Per share
Balance sheet
Liquidity

EPS

$3.42

Free cash flow per share

$5.22

Book value per share

$13.5

Revenue per share

$11.34

TBVPS

$18.43

Total assets

$179.19B

Total liabilities

$103.22B

Debt

$39.88B

Equity

$75.69B

Working capital

$16.1B

Debt to equity

0.53

Current ratio

1.39

Quick ratio

0.99

Net debt/EBITDA

1.51

Margins
Efficiency
Dividend

EBITDA margin

39.6%

Gross margin

64.3%

Net margin

30.2%

Operating margin

27.7%

Return on assets

11.6%

Return on equity

27.6%

Return on invested capital

21.6%

Return on capital employed

14.7%

Return on sales

31.8%

Dividend yield

2.91%

DPS

$1.56

Payout ratio

45.6%

How has the Pfizer stock price performed over time

Intraday

1.08%

1 week

-0.87%

1 month

-9.49%

1 year

47.85%

YTD

-9.26%

QTD

-9.26%

How have Pfizer's revenue and profit performed over time

Revenue

$63.6B

Gross profit

$40.86B

Operating income

$17.61B

Net income

$19.18B

Gross margin

64.3%

Net margin

30.2%

Pfizer's net income has surged by 140% YoY and by 53% QoQ

Pfizer's revenue has surged by 97% YoY and by 28% QoQ

The operating income has soared by 70% from the previous quarter

Pfizer's gross profit has soared by 58% YoY and by 17% from the previous quarter

What is Pfizer's growth rate over time

What is Pfizer stock price valuation

P/E

15.67

P/B

3.97

P/S

4.73

EV/EBIT

16.76

EV/EBITDA

13.46

EV/Sales

5.32

Pfizer's EPS has soared by 139% YoY and by 53% from the previous quarter

The price to earnings (P/E) is 13% lower than the last 4 quarters average of 17.8 and 9% lower than the 5-year quarterly average of 17.1

PFE's P/B is 27% above its last 4 quarters average of 3.1 and 19% above its 5-year quarterly average of 3.3

Pfizer's equity has increased by 16% YoY and by 8% QoQ

Pfizer's revenue has surged by 97% YoY and by 28% QoQ

PFE's P/S is 4% above its last 4 quarters average of 4.5 but 2.5% below its 5-year quarterly average of 4.8

How efficient is Pfizer business performance

Pfizer's ROA has soared by 152% YoY and by 53% from the previous quarter

The ROE has soared by 123% YoY and by 48% QoQ

Pfizer's ROS has soared by 59% YoY and by 17% from the previous quarter

The company's return on invested capital has surged by 55% QoQ

What is PFE's dividend history

DPS

$1.56

Dividend yield

2.91%

Payout ratio

45.6%

Recent dividends

How did Pfizer financials performed over time

PFE's total assets is 74% greater than its total liabilities

The quick ratio has grown by 9% from the previous quarter and by 6% YoY

The company's total liabilities fell by 9% YoY but it rose by 3.6% QoQ

PFE's debt is 47% less than its equity

The debt to equity has contracted by 45% YoY and by 5% from the previous quarter

PFE's debt is down by 37% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.